These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 18284706)
41. The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China. Qiu LL; Hua PY; Ye LL; Wang YC; Qiu T; Bao HZ; Wang L Cancer Detect Prev; 2007; 31(1):45-9. PubMed ID: 17292563 [TBL] [Abstract][Full Text] [Related]
42. Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment. Zalcman G; Schlichtholz B; Trédaniel J; Urban T; Lubin R; Dubois I; Milleron B; Hirsch A; Soussi T Clin Cancer Res; 1998 Jun; 4(6):1359-66. PubMed ID: 9626451 [TBL] [Abstract][Full Text] [Related]
43. A novel algorithm to improve specificity in ovarian cancer detection. Arjomandi A; Delanoy ML; Walker RP; Binder SR Cancer Treat Res Commun; 2018; 15():32-35. PubMed ID: 30207285 [TBL] [Abstract][Full Text] [Related]
44. Usefulness of serum anti-p53 antibody assay for lung cancer diagnosis. Park Y; Kim Y; Lee JH; Lee EY; Kim HS Arch Pathol Lab Med; 2011 Dec; 135(12):1570-5. PubMed ID: 22129186 [TBL] [Abstract][Full Text] [Related]
45. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens. Dai L; Li J; Ortega R; Qian W; Casiano CA; Zhang JY J Immunol Res; 2014; 2014():827827. PubMed ID: 24860838 [TBL] [Abstract][Full Text] [Related]
46. Biotin-avidin immobilization of platelet glycoproteins (BAIPG): a new capture assay for the detection of anti-platelet antibodies. Cordiano I; Steffan A; Randi ML; Pradella P; Girolami A; Fabris F J Immunol Methods; 1995 Jan; 178(1):121-30. PubMed ID: 7829861 [TBL] [Abstract][Full Text] [Related]
47. Autoantibodies to IA-2 in type 1 diabetes: measurements with a new enzyme-linked immunosorbent assay. Kawasaki E; Yamaguchi H; Hattori H; Egashira T; Eguchi K Ann N Y Acad Sci; 2002 Apr; 958():241-6. PubMed ID: 12021115 [TBL] [Abstract][Full Text] [Related]
48. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer. Ma H; Wu T; Zhang Q; Ding Q BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432 [TBL] [Abstract][Full Text] [Related]
49. [Serum p53 antibody assay: evaluation in colorectal cancer]. Hammel P; Soussi T Rev Med Interne; 2000 Feb; 21(2):167-73. PubMed ID: 10703073 [TBL] [Abstract][Full Text] [Related]
50. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. Rohayem J; Diestelkoetter P; Weigle B; Oehmichen A; Schmitz M; Mehlhorn J; Conrad K; Rieber EP Cancer Res; 2000 Apr; 60(7):1815-7. PubMed ID: 10766164 [TBL] [Abstract][Full Text] [Related]
51. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer. Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220 [TBL] [Abstract][Full Text] [Related]
52. Detection of serum anti-P53 antibodies from patients with colorectal cancer in China using a combination of P53- and phage-ELISA: correlation to clinical parameters. Wu J; Qiu T; Pan P; Yu D; Ju Z; Qu X; Gao X; Mao C; Wang L Asian Pac J Cancer Prev; 2011; 12(11):2921-4. PubMed ID: 22393964 [TBL] [Abstract][Full Text] [Related]
53. p53 autoantibodies predict subsequent development of cancer. Li Y; Karjalainen A; Koskinen H; Hemminki K; Vainio H; Shnaidman M; Ying Z; Pukkala E; Brandt-Rauf PW Int J Cancer; 2005 Mar; 114(1):157-60. PubMed ID: 15523685 [TBL] [Abstract][Full Text] [Related]
54. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis. Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095 [TBL] [Abstract][Full Text] [Related]
55. Detection of circulating anti-mucin 1 (MUC1) antibodies in breast tumor patients by indirect enzyme-linked immunosorbent assay using a recombinant MUC1 protein containing six tandem repeats and expressed in Escherichia coli. Tang Y; Wang L; Zhang P; Wei H; Gao R; Liu X; Yu Y; Wang L Clin Vaccine Immunol; 2010 Dec; 17(12):1903-8. PubMed ID: 20876819 [TBL] [Abstract][Full Text] [Related]
56. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera. Yang Z; Chevolot Y; Géhin T; Solassol J; Mange A; Souteyrand E; Laurenceau E Biosens Bioelectron; 2013 Feb; 40(1):385-92. PubMed ID: 23017679 [TBL] [Abstract][Full Text] [Related]
57. Absence of p53 autoantibodies in a significant proportion of breast cancer patients. Vojtesek B; Kovarik J; Dolezalova H; Nenutil R; Havlis P; Brentani RR; Lane DP Br J Cancer; 1995 Jun; 71(6):1253-6. PubMed ID: 7779720 [TBL] [Abstract][Full Text] [Related]
58. Serum anti-p53 antibodies in lung cancer: comparison with established tumor markers. Cioffi M; Vietri MT; Gazzerro P; Magnetta R; D'Auria A; Durante A; Nola E; Puca GA; Molinari AM Lung Cancer; 2001; 33(2-3):163-9. PubMed ID: 11551411 [TBL] [Abstract][Full Text] [Related]
59. Identification of tumor-associated antigens of lung cancer: SEREX combined with bioinformatics analysis. Wang Y; Wang P; Liu M; Zhang X; Si Q; Yang T; Ye H; Song C; Shi J; Wang K; Wang X; Zhang J; Dai L J Immunol Methods; 2021 May; 492():112991. PubMed ID: 33587914 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer. Wang P; Song C; Xie W; Ye H; Wang K; Dai L; Zhang Y; Zhang J J Immunol Res; 2014; 2014():512540. PubMed ID: 24822225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]